[eBook] Therapeutic proteins: bioprocessing methods for mAb generation
Supplied by Eppendorf on Wednesday, 20 November, 2024
Antibodies have long been vital in research and diagnostics, but their lab utility was limited by their polyclonal nature. To stay competitive, production must become more efficient, cost-effective, and higher in quality.
Download this eBook to learn about:
·key methods for mAb validation and development
·the potential of P. pastoris as a next-gen mAb production platform
·strategies for ensuring reliable, reproducible mAb research and drug development.
Related White Papers
[AMCA Impact Study] How AI is Reducing Safety Documentation Time by 90%
Discover how AMCA is reducing administration,...
Assessing bacterial viability
Assessment of bacterial viability is crucial to many applications ranging from the production...
How to re-socialise your workplace post COVID-19
Learn how to reimagine your workspace, take full advantage of workplace socialisation and...
